ATPγS Enhances the Production of Inflammatory Mediators by a Human Dermal Endothelial Cell Line via Purinergic Receptor Signaling
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Adenosine 5'-triphosphate (ATP) affects multiple intra- and extracellular processes, including vascular tone and immune responses. Microvascular endothelial cells (EC) play a central role in inflammation by recruitment of inflammatory cells from blood to tissues. We hypothesized that ATP (secreted by neurons and/or released after perturbation of cutaneous cells) may influence secretion of inflammatory messengers by dermal microvascular EC through actions on purinergic P2 receptors. Addition of the hydrolysis-resistant ATP analogue, adenosine 5'-O-(3-thiotriphosphate) (ATPgammaS), to subconfluent cultures of the human microvascular endothelial cell-1 (HMEC-1) cell line led to a dose- and time-dependent increase in release of IL-6, IL-8, monocyte chemoattractant protein-1, and growth-regulated oncogene alpha. Both ATPgammaS-induced release and basal production of these proteins were significantly inhibited by the purinergic antagonists pyridoxal-5'-phosphate-6-azophenyl-2',5'-disulfonic acid (PPADS), pyridoxal-5'-phosphate-6(2'-naphthylazo-6-nitro-4',8'-disulfonate), and suramin. ATPgammaS increased expression of intercellular adhesion molecule-1 (ICAM-1), whereas suramin and PPADS decreased both ATPgammaS-induced and basal ICAM-1 expression. Using PCR, we found that HMEC-1 strongly express mRNA for the P2X(4), P2X(5), P2X(7), P2Y(2), and P2Y(11) receptors and weakly express mRNA for P2X(1) and P2X(3) receptors. Purinergic nucleotides may mediate acute inflammation in the skin and thus contribute to physiological and pathophysiological inflammation. For example, ATP may contribute to both the vasodilation and the inflammation associated with rosacea.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recognition of extracellular ATP by P2X7 elicits the release of intracellular potassium and an increase in cytosolic calcium, resulting in activation of NLRP3 and downstream release of pro-inflammatory cytokines (for example, IL-1β, IL-6 and IL-8 and MCP1)198–200.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [199]
Citations
Cites
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958 · cited 2×
“Nevertheless, that suramin is only a weak antagonist at P2Y2 (Ralevic and Burnstock, 1998) would argue against P2Y2 as the only receptor involved.”
BackgroundReceptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Extracellular ATP: effects, sources and fate
Gordon, J. L. (1986) · Biochemical Journal · doi:10.1042/bj2330309 · Cited by 1,658 · cited 1×
“Because endothelial ectonucleotidases are effective scavengers of ATP, actual concentrations in the immediate vicinity of release may be even higher (Gordon 1986).”
BackgroundHMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265 · cited 1×
“MATERIALS AND METHODS Media and cell lines The transformed human dermal microvascular EC line HMEC-1 (Ades et al., 1992), which was immortalized by simian virus 40 transformation, was the kind gift of T.”
MethodSignal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
Dubyak, G. R., & el-Moatassim, C. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.3.c577 · Cited by 1,237 · cited 2×
“Purinergic agents and cell death As extracellular ATP has been reported to cause apoptosis and cell death in various cell types, including lymphocytes (Dubyak and el-Moatassim, 1993) and keratinocytes (Greig et al.”
BackgroundMethodMonocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.
Carr, M. W., Roth, S. J., Luther, E., Rose, S. S., & Springer, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3652 · Cited by 1,198 · cited 1×
“, 1994) as well as memory T cells (Carr et al., 1994).”
BackgroundRapid Secretion of Interleukin-1β by Microvesicle Shedding
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 863
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
Burnstock, G., & Knight, G. E. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)40002-3 · Cited by 795
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., & Baricordi, O. R. (2001) · Blood · doi:10.1182/blood.v97.3.587 · Cited by 703
Purinergic Signalling: ATP Release
Bodin, P., & Burnstock, G. (2001) · Neurochemical Research · doi:10.1023/a:1012388618693 · Cited by 521 · cited 1×
“ATP also serves as an extracellular signaling molecule involved in vascular tone, synaptic transmission, and cell death (Bodin and Burnstock, 2001; Burnstock, 2002).”
BackgroundPurinergic Signaling and Vascular Cell Proliferation and Death
Burnstock, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105360 · Cited by 414 · cited 1×
“ATP also serves as an extracellular signaling molecule involved in vascular tone, synaptic transmission, and cell death (Bodin and Burnstock, 2001; Burnstock, 2002).”
BackgroundAbbracchio, M. P., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Miras-Portugal, M. T., King, B. F., Gachet, C., Jacobson, K. A., Weisman, G. A., et al. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00038-x · Cited by 413 · cited 2×
“There are currently seven recognized mammalian P2X receptors (P2X1 7) and at least eight P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, P2Y14) (Di Virgilio et al., 2001; Abbracchio et al., 2003).”
BackgroundRollins, B., Walz, A., & Baggiolini, M. (1991) · Blood · doi:10.1182/blood.v78.4.1112.1112 · Cited by 369
Adenosine in the spinal cord and periphery: release and regulation of pain
Sawynok, J., & Liu, X. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00050-9 · Cited by 353 · cited 1×
“Possible other sources of paracrine ATP release are neuronal cells following inflammation and injury (Sawynok and Liu, 2003), and human keratinocytes under static conditions (Dixon et al.”
BackgroundPurine and Pyrimidine (P2) Receptors as Drug Targets
Jacobson, K. A., Jarvis, M. F., & Williams, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020046y · Cited by 352 · cited 3×
“P2X4 receptors are unlikely targets as well, as they are relatively insensitive to suramin (Jacobson et al., 2002), which proved to be the strongest antagonist in our studies.”
BackgroundInfluentialLoetscher, P., Seitz, M., Lewis, I. C., Baggiolini, M., & Moser, B. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926371 · Cited by 323 · cited 1×
“, 1992), and to chemoattract both CD4þ and CD8þ T lymphocytes (Loetscher et al., 1994) as well as memory T cells (Carr et al.”
BackgroundLoss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation
Robson, S. C., Kaczmarek, E., Siegel, J. B., Candinas, D., Koziak, K., Millan, M., Hancock, W. W., & Bach, F. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.153 · Cited by 279 · cited 1×
“For example, the local concentration of ATP during inflammation may increase as a consequence of inactivation of ecto-ATPases by oxygen radicals (Robson et al., 1997).”
BackgroundPharmacological characterization of the human P2Y11 receptor
Communi, D., Robaye, B., & Boeynaems, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702909 · Cited by 271 · cited 2×
“Suramin is the most effective antagonist at P2Y11, whereas PPADS is inactive (Communi et al., 1999; Wilkin et al., 2001).”
BackgroundResultBorn, G. V., & Kratzer, M. A. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015385 · Cited by 268
Chemokines in rapid leukocyte adhesion triggering and migration
Johnston, B., & Butcher, E. C. (2002) · Seminars in Immunology · doi:10.1006/smim.2001.0345 · Cited by 247 · cited 2×
“To attract leukocytes to areas of inflammation, EC also express adhesion molecules and produce a number of chemokines that bind to and signal through specific receptors on leukocytes (Johnston and Butcher, 2002).”
BackgroundKOIZUMI, S., FUJISHITA, K., INOUE, K., SHIGEMOTO-MOGAMI, Y., TSUDA, M., & INOUE, K. (2004) · Biochemical Journal · doi:10.1042/bj20031089 · Cited by 235
P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells
Wang, L., Karlsson, L., Moses, S., Hultgårdh-Nilsson, A., Andersson, M., Borna, C., Gudbjartsson, T., Jern, S., & Erlinge, D. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200212000-00005 · Cited by 220 · cited 2×
“Purinergic receptors are expressed on a multitude of cells that influence immune functions, including macro- and microvascular endothelial cells (EC) (Yamamoto et al., 2000; Wang et al., 2002; Burnstock and Knight, 2004) and there is evidence that ATP increases leukocyte locomotion (Saito et al.”
BackgroundThe P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells
Wilkin, F., Duhant, X., Bruyns, C., Suarez-Huerta, N., Boeynaems, J.-M., & Robaye, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7172 · Cited by 200 · cited 2×
“Suramin is the most effective antagonist at P2Y11, whereas PPADS is inactive (Communi et al., 1999; Wilkin et al., 2001).”
BackgroundResultBouma, M. G., van den Wildenberg, F. A., & Buurman, W. A. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.2.c522 · Cited by 200 · cited 1×
“In contrast to the proinflammatory function associated with ATP, adenosine dose-dependently inhibits the release of IL-6 and IL-8, as well as the expression of E-selectin and VCAM-1 by activated EC (Bouma et al., 1996).”
BackgroundP2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells
Yamamoto, K., Korenaga, R., Kamiya, A., Qi, Z., Sokabe, M., & Ando, J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.1.h285 · Cited by 198 · cited 3×
“, 2002), with P2X4 being predominantly expressed (Yamamoto et al., 2000).”
BackgroundLidington, E. A., Moyes, D. L., McCormack, A. M., & Rose, M. L. (1999) · Transplant Immunology · doi:10.1016/s0966-3274(99)80008-2 · Cited by 185 · cited 2×
“Induction of these factors has been achieved by stimulation with IL-1b, IFN-g, and tumor necrosis factor (TNF) a in both freshly prepared human dermal microvascular endothelial cells and transformed HMEC-1 cells (Goebeler et al., 1997; Lidington et al., 1999).”
BackgroundMethodAgonists and antagonists acting at P2X receptors: selectivity profiles and functional implications
Lambrecht, G. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000312 · Cited by 178 · cited 6×
“Based on the efficacy profiles of agonists (ATP4ATPgSbUTP4BzATPb2MeSATP1⁄4 a,bmeATP) and antagonists seen in this study, P2X7 seems an unlikely candidate for the induction of cytokines, since ATPgS has been shown to not activate or only weakly activate this receptor, whereas BzATP should be its most potent agonist (La…”
BackgroundInfluentialKuna, P., Reddigari, S. R., Rucinski, D., Oppenheim, J. J., & Kaplan, A. P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.489 · Cited by 178 · cited 1×
“, 1991), to chemoattract and stimulate histamine release from basophils (Kuna et al., 1992), and to chemoattract both CD4þ and CD8þ T lymphocytes (Loetscher et al.”
BackgroundGeorgala, S., Katoulis, A., Kylafis, G., Koumantaki‐Mathioudaki, E., Georgala, C., & Aroni, K. (2001) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2001.00331.x · Cited by 173
Solini, A., Chiozzi, P., Morelli, A., Fellin, R., & Di Virgilio, F. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.297 · Cited by 160
Schwiebert, L. M., Rice, W. C., Kudlow, B. A., Taylor, A. L., & Schwiebert, E. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.01387.2000 · Cited by 151 · cited 1×
“In human macrovascular EC from multiple sources, expression of P2X1 7 as well as P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 has been documented (Pirotton et al., 1996; Yamamoto et al., 2000; Glass et al., 2002; Ray et al., 2002; Schwiebert et al., 2002; Wang et al., 2002), with P2X4 being predominantly expressed (Yamamoto et a…”
BackgroundPharmacological and Biophysical Properties of the Human P2X5 Receptor
Bo, X., Jiang, L., Wilson, H. L., Kim, M., Burnstock, G., Surprenant, A., & North, R. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1407 · Cited by 142 · cited 1×
“2 mM) (Bo et al., 2003), which was the weakest antagonist in our study.”
BackgroundRandolph, G. J., & Furie, M. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.7.3610 · Cited by 141 · cited 1×
“Because apically released MCP-1, due to flow conditions, is more readily diluted than the MCP-1 fraction secreted into the subendothelial matrix, a soluble gradient that promotes transendothelial migration of monocytes is established (Randolph and Furie, 1995).”
BackgroundXu, Y., Swerlick, R. A., Sepp, N. T., Bosse, D. C., Ades, E. W., & Lawley, T. J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12382086 · Cited by 138 · cited 1×
“These cells retain the properties of microvascular EC and are frequently used to study EC function (Xu et al., 1994; Goebeler et al., 1997).”
BackgroundRole of Microvascular Endothelial Cells in Inflammation
Swerlick, R. A., & Lawley, T. J. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.33 · Cited by 134 · cited 4×
“EC are important sources of a number of proinflammatory cytokines and chemokines, among them IL-6, IL-8 (CCL-8), GROa (CXCL1), and MCP-1 (CCL2) (Swerlick and Lawley, 1993) and express adhesion molecules such as ICAM-1 and VCAM-1 (Lidington et al.”
BackgroundInfluentialSIGNALING BY EXTRACELLULAR NUCLEOTIDES
Brake, A. J., & Julius, D. J. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.519 · Cited by 128 · cited 2×
“Because ATP is rapidly hydrolyzed to ADP, adenosine monophosphate, and finally adenosine through the action of ectonucleotidases, which are expressed on EC (Dubyak and el-Moatassim, 1993; Brake and Julius, 1996), we used the hydrolysis-resistant, long-lived ATP agonist ATPgS for functional studies.”
BackgroundMethodSome aspects of IL-8 pathophysiology III: chemokine interaction with endothelial cells
Rot, A., Hub, E., Middleton, J., Pons, F., Rabeck, C., Thierer, K., Wintle, J., Wolff, B., Zsak, M., & Dukor, P. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.1.39 · Cited by 126 · cited 1×
“IL-8 and GROa, both members of the CXC subfamily of chemokines, bind to the endothelium and preferentially attract and activate neutrophils (Rot et al., 1996; Johnston and Butcher, 2002).”
BackgroundGreig, A. V. H., Linge, C., Terenghi, G., McGrouther, D. A., & Burnstock, G. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12261.x · Cited by 124
Human Endothelial Cell Presentation of Antigen and the Homing of Memory/Effector T Cells to Skin
POBER, J. S., KLUGER, M. S., & SCHECHNER, J. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03706.x · Cited by 119 · cited 2×
“The expression of ICAM-1 in HMEC-1 cells is increased by ATPcS and inhibited by the purinergic antagonists suramin and PPADS To recruit leukocytes from the blood to inflamed tissues, EC express adhesion molecules, such as ICAM-1 and vascular cellular adhesion molecule-1 (VCAM-1), that facilitate migration of lymphocyt…”
BackgroundPaquet, P., & Piérard, G. E. (1996) · International Archives of Allergy and Immunology · doi:10.1159/000237257 · Cited by 119 · cited 1×
“In fact, IL-6 functions as a broad stimulator of immune responses (Paquet and Pierard, 1996).”
BackgroundGoebeler, M., Yoshimura, T., Toksoy, A., Ritter, U., Bröcker, E., & Gillitzer, R. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12289711 · Cited by 116
Regulation of epidermal homeostasis through P2Y2receptors
Dixon, C. J., Bowler, W. B., Littlewood-Evans, A. J., Dillon, J. P., Bilbe, G., Sharpe, G. R., & Gallagher, J. A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702653 · Cited by 113 · cited 2×
“Since keratinocytes express purinergic receptors (Dixon et al., 1999; Greig et al., 2003a) and could yield a confounding signal when a highly sensitive method such as PCR is employed with freshly isolated dermal EC, we used the cell line HMEC-1 as a surrogate for native cells.”
BackgroundMethodWilson, H. L., Francis, S. E., Dower, S. K., & Crossman, D. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1202 · Cited by 103
Greig, A. V. H., Linge, C., Cambrey, A. D., & Burnstock, G. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12567.x · Cited by 93
Burrell, H. E., Bowler, W. B., Gallagher, J. A., & Sharpe, G. R. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12050.x · Cited by 74 · cited 1×
“Furthermore, it is likely that ATP released by microvascular EC could also act on purinergic receptor-expressing skin cells, such as keratinocytes and fibroblasts, where ATP has been shown to increase intracellular Ca2þ , cell growth and differentiation, release of IL-6, and apoptosis (Solini et al., 1999; Burrell et…”
BackgroundRay, F. R., Huang, W. C. W., Slater, M., & Barden, J. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00681-5 · Cited by 72 · cited 1×
“In human macrovascular EC from multiple sources, expression of P2X1 7 as well as P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 has been documented (Pirotton et al., 1996; Yamamoto et al., 2000; Glass et al., 2002; Ray et al., 2002; Schwiebert et al., 2002; Wang et al., 2002), with P2X4 being predominantly expressed (Yamamoto et a…”
BackgroundP2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells
Glass, R., Loesch, A., Bodin, P., & Burnstock, G. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8474-y · Cited by 65 · cited 1×
“In human macrovascular EC from multiple sources, expression of P2X1 7 as well as P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 has been documented (Pirotton et al., 1996; Yamamoto et al., 2000; Glass et al., 2002; Ray et al., 2002; Schwiebert et al., 2002; Wang et al., 2002), with P2X4 being predominantly expressed (Yamamoto et a…”
BackgroundMizumoto, N., Mummert, M. E., Shalhevet, D., & Takashima, A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12558.x · Cited by 64 · cited 1×
“, 1999) and after chemical injury (Mizumoto et al., 2003).”
Characterization of Multiple P2X Receptors in Cultured Normal Human Epidermal Keratinocytes
Inoue, K., Denda, M., Tozaki‐Saitoh, H., Fujishita, K., Koizumi, S., & Inoue, K. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23683.x · Cited by 62 · cited 1×
“Furthermore, it is likely that ATP released by microvascular EC could also act on purinergic receptor-expressing skin cells, such as keratinocytes and fibroblasts, where ATP has been shown to increase intracellular Ca2þ , cell growth and differentiation, release of IL-6, and apoptosis (Solini et al., 1999; Burrell et…”
BackgroundMolecular Recognition at Purine and Pyrimidine Nucleotide (P2) Receptors
Jacobson, K. A., Costanzi, S., Ohno, M., Joshi, B. V., Besada, P., Xu, B., & Tchilibon, S. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043450961 · Cited by 53 · cited 1×
“Based on the efficacy profiles of agonists (ATP4ATPgSbUTP4BzATPb2MeSATP1⁄4 a,bmeATP) and antagonists seen in this study, P2X7 seems an unlikely candidate for the induction of cytokines, since ATPgS has been shown to not activate or only weakly activate this receptor, whereas BzATP should be its most potent agonist (La…”
BackgroundExtracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries
Liu, C., Mather, S., Huang, Y., Garland, C. J., & Yao, X. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00576.2003 · Cited by 48 · cited 2×
“ATP can, indeed, be released from EC under physiological conditions (Liu et al., 2004).”
BackgroundDawicki, D. D., McGowan-Jordan, J., Bullard, S., Pond, S., & Rounds, S. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.4.l666 · Cited by 46 · cited 2×
“More recently, ATP has been appreciated as a regulator of directed migration of leukocytes towards and adherence to activated EC (Dawicki et al., 1995; Parker et al., 1996; Rounds et al., 1999).”
BackgroundLeukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Virgilio, F., Baricordi, O., Romagnoli, R., & Baraldi, P. (2005) · Current Drug Target -Cardiovascular & Hematological Disorders · doi:10.2174/1568006053004967 · Cited by 44
Endothelial cell biology, perivascular inflammation, and vasculitis.
Cid, M. C. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_2.sii45 · Cited by 39 · cited 1×
“Apart from IL-8 (also known as CCL8), these include the chemokines monocyte chemotactic protein-1 (MCP-1) (CCL2), regulated upon activation, normal T cell expressed and secreted protein (RANTES) (CCL5), secondary lymphoid-tissue chemokine (SLC) (CCL21), and growth-regulated oncogene a (GROa) (CXCL1) (Cid, 2002).”
BackgroundEndothelial P2‐purinoceptors: subtypes and signal transduction
Pirotton, S., Communi, D., Moue, S., Janssens, R., & Boeynaems, J. M. (1996) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1996.tb00052.x · Cited by 39 · cited 1×
“In human macrovascular EC from multiple sources, expression of P2X1 7 as well as P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 has been documented (Pirotton et al., 1996; Yamamoto et al., 2000; Glass et al., 2002; Ray et al., 2002; Schwiebert et al., 2002; Wang et al., 2002), with P2X4 being predominantly expressed (Yamamoto et a…”
BackgroundMechanism of ATP-induced leukocyte adherence to cultured pulmonary artery endothelial cells
Parker, A. L., Likar, L. L., Dawicki, D. D., & Rounds, S. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.270.5.l695 · Cited by 24
Saito, H., Ebisawa, M., Reason, D. C., Ohno, K., Kurihara, K., Sakaguchi, N., Ohgimi, A., Saito, E., Akasawa, A., Akimoto, K., et al. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235327 · Cited by 22 · cited 1×
“, 2002; Burnstock and Knight, 2004) and there is evidence that ATP increases leukocyte locomotion (Saito et al., 1991) and adhesion of leucocytes to EC via purinergic receptors (Dawicki et al.”
BackgroundNucleotide-induced PMN adhesion to cultured epithelial cells: possible role of MUC1 mucin
Rounds, S., Likar, L. L., Harrington, E. O., Kim, K. C., Smeglin, A. M., Heins, K., & Parks, N. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.5.l874 · Cited by 17 · cited 2×
“More recently, ATP has been appreciated as a regulator of directed migration of leukocytes towards and adherence to activated EC (Dawicki et al., 1995; Parker et al., 1996; Rounds et al., 1999).”
Background
Cited by
Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
P2 receptors in cardiovascular regulation and disease
Erlinge, D., & Burnstock, G. (2008) · Purinergic Signalling · doi:10.1007/s11302-007-9078-7 · Cited by 344
“ATP stimulates release of IL-6, IL-8, monocyte chemoattractant protein-1, growth-regulated oncogene α and increased expression of intercellular adhesion molecule-1 in human microvascular endothelial cells [118].”
BackgroundNeurovascular contributions to migraine: Moving beyond vasodilation
Jacobs, B., & Dussor, G. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.012 · Cited by 183
“The activation of purinergic receptors on endothelial cells also stimulates proflammatory pathways (Erlinge and Burnstock, 2008) including the release of interleukins (Seiffert et al., 2006) known to sensitize meningeal afferents (Zhang et al., 2010; Yan et al., 2012).”
InfluentialMitochondrial damage-associated molecular patterns and vascular function
Wenceslau, C. F., McCarthy, C. G., Szasz, T., Spitler, K., Goulopoulou, S., Webb, R. C., & Working Group on DAMPs in Cardiovascular Disease (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu047 · Cited by 135
“thelial cells leading to the releaseof IL-6, IL-8, andMCP-1and increase ICAM-1 expression.(44) Our lab has shown that lipopolysaccharideinduced vascular hyporeactivity is amplified following P2X7 receptor activation.”
BackgroundInoue, K., Hosoi, J., & Denda, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700526 · Cited by 114
Metadata
- Authors
- Seiffert, K., Ding, W., Wagner, J. A., & Granstein, R. D.
- Affiliations
- Cornell University (US)
- Corresponding author
- Granstein, Richard D.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 126
- Issue
- 5
- Pages
- 1017-1027
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2046207517
- Cited by
- 62
- References
- 59
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 7 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3502 d)
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Rosacea Society
- Edith C. Blum Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- ATP gamma S, purinergic receptors, microvascular endothelial cells, HMEC-1, P2X receptors, P2Y receptors, ICAM-1, interleukin-6, interleukin-8, MCP-1, CXCL1, PPADS, suramin, rosacea, vasodilation
- MeSH terms
- Adenosine Triphosphate, Cell Line, Humans, Inflammation, Pyridoxal Phosphate, Receptors, Purinergic, Skin, Suramin, Signal Transduction, Interleukin-6, Interleukin-8, Apoptosis, Receptors, Purinergic P2, Intercellular Adhesion Molecule-1, Inflammation Mediators, Chemokine CCL2, Chemokines, CXC, Intercellular Signaling Peptides and Proteins, Endothelial Cells, Chemokine CXCL1, Receptors, Purinergic P2X
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.